Pine Labs announces a strong financial performance for FY26, reaching INR 1926.1 crore in revenue and INR 178.8 crore in PBT. The company provides updates on how IPO proceeds are being utilized, employee stock options, and the acquisition of a new subsidiary.

On May 26th, numerous companies such as IRCTC, ONGC, Siemens, AstraZeneca, JK Tyre, Bayer CropScience, EID Parry, Gujarat Fluorochemicals, and GIC India will be releasing their Q4FY26 financial results. Investors eagerly await updates from these firms on their recent performances.

Morgan Stanley maintains its neutral stance on Pine Labs, predicting a potential price of INR 245, suggesting steady performance for the financial technology company.

Madison India has sold a 2.2% stake in Pine Labs for approximately INR 357 crores, reducing their holdings. This move signifies a strategic decision by Madison India to adjust their investment portfolio.

HSBC Mutual Fund has acquired approximately 6.17 million shares of Pine Labs, with an average purchase price of around ₹144 per share. This investment signifies a growing interest in the digital payments company from global financial institutions.

Investment firm Templeton has purchased approximately 133,000 shares of Pine Labs, each worth Rs.144, marking a new investment in the company by Templeton's Developing Markets VIP Fund.

Franklin Templeton has purchased a significant number of shares in Pine Labs Ltd, with the average price being ₹144 per share. The transaction was facilitated through Franklin Templeton's SMACS Series EM investment trust on the National Stock Exchange.

Morgan Stanley Asia Singapore has invested in Pine Labs to the tune of approximately 25 crores INR, purchasing 3.3 million shares at ₹144 each. This move suggests continued confidence in the growth potential of Pine Labs.

Pine Labs has secured a significant investment of INR 356 crores through a block deal, representing approximately 2.2% equity stake in the company. This substantial infusion underscores the confidence investors have in the company's potential growth trajectory.

Pine Labs' shares experienced a 10% drop following the end of their lock-in period, making approximately Rs 15,019 crore available for trading on open markets. The expiration of lock-ins also applies to Groww and Lenskart, releasing an additional Rs 1.43 lakh crore for trading in total.

Pine Labs has implemented a 6-month lock-in period for 924 million shares, representing 80% of its total outstanding stock. This move is intended to stabilize the market by restricting significant share transactions during this period.

On May 25, 2026, Pine Labs will hold a board meeting to finalize their Q4 and FY26 financial results. They will then share these results in an investor call on the following day, May 26, at 8:00 AM IST. For more information about the call, please visit their official website.

Pine Labs has purchased Shopflo Technologies for up to ₹88 Crore, aiming to bolster their unified commerce platform. Shopflo's technology focuses on optimizing checkouts and enhancing consumer engagement, promising a 15-20% increase in conversion rates for D2C merchants.

Citi has recommended buying Pine Labs' shares with a target price of ₹235, highlighting its strong leadership, profit-oriented approach, and stable market position. The payments fintech firm is expected to grow due to improved monetization strategies, increasing regulatory compliance demands, and robust enterprise integrations.

Starting April 15, shares worth Rs 5 crore will become accessible for key companies like Tata Capital, Meesho, LG India, and Pine Labs as IPO lock-in periods end. According to Nuvama's report, by July 2026, approximately 81 firms are anticipated to release shares, with significant shifts in share eligibility for major market players.

JPMorgan views Pine Labs as neutral with a target price of ₹165, driven by anticipated growth of 23-25% in the digital payments market. The firm anticipates a high EBITDA margin approaching 27% by FY28, thanks to a robust merchant network. However, revenue growth is expected to slow down slightly, with a CAGR of around 17%.